Fascioliasis and Fasciolopsiasis

  • George V. Hillyer
Chapter

Abstract

Fascioliasis is a disease caused by digenetic trematodes of the genus Fasciola; F. hepatica and F. gigantica are the two species causing human disease. Fasciolopsis buski, also a digenetic trematode, causes fasciolopsiasis.

Keywords

Bile Duct Adult Worm Ventral Sucker Digenetic Trematode Snail Intermediate Host 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. Barlow, C. H. 1925. The life cycle of the human intestinal fluke Fasciolopsis buski (Lankester). Am. J. Hyg. mongr. series, no. 4Google Scholar
  2. Beaver, P. C., R. C. Jung, and E. W. Cupp. 1984. Clinical parasitology, 9th ed. Lea & Febiger, Philadelphia.Google Scholar
  3. Bendezú, P., A. Frame, and G. V. Hillyer. 1982. Human fascioliasis in Corozal, Puerto Rico. J. Parasitol. 68:297–299.PubMedCrossRefGoogle Scholar
  4. Bennett, J. L. and P. Köhler. 1987. Fasciola hepatica: action in vitro of triclabendazole on immature and adult stages. Exp. Parasit. 63:49–57.PubMedCrossRefGoogle Scholar
  5. Biguet, J., A. Capron, and P. Tran Van Ky. 1962. Les antigenes de Fasciola hepatica. Etude electrophore- tique et immunoeléctrophoretique. Identification des fractions et comparaison avec les antigènes correspondant a sept autres helminthes. Ann. Parasitol. Hum. Comp. 37:221–231.Google Scholar
  6. Boray, J. C. 1982. Fascioliasis, p. 71–88. In J. H. Steele, G. V. Hillyer, and C. E. Hopla (ed.), CRC handbook series in zoonoses. Section C: parasitic zoonoses, vol. III. CRC Press, Inc., Boca Raton, FlaGoogle Scholar
  7. Boray, J. C., and K. Enigk. 1964. Laboratory studies on the survival and infectivity of Fasciola hepatica- and F. gigantica-metacercariae. Z. Tropenmed. Parasitol. 15:324–331.PubMedGoogle Scholar
  8. Campbell, W. C., and E. G. Garcia. 1986. Trematode infections in man, p. 385–399. In W. C. Campbell and R. S. Rew (ed.), Chemotherapy of parasitic diseases. Plenum Publishing Corp., New York.Google Scholar
  9. Capron, A., A. Vernes, and J. Fruit. 1971. Le diagnostic immunologique de la distomatose hépatica à F. hepatica. Bilan personnel à propos de 430 observations. Etude comparée de trois techniques diagnostiques (immunoelectrophorese, reaction de fixation de complement et immunofluorescence). Rev. Pathol. Comp. 70:31–36.Google Scholar
  10. Connor, D. H., and R. C. Neafie. 1976. Fasciolopsiasis, p. 528–529. In C. H. Binford and D. H. Connor (ed.), Pathology of tropical and extraordinary diseases, vol. 2, Armed Forces Institute of Pathology, Washington, D.C.Google Scholar
  11. Cross, J. H. 1969. Fasciolopsiasis in southeast Asia and the Far East: a review, p. 177–196. In C. Harinasuta (ed.), Proceedings of the Fourth Southeast Asian Seminar on Parasitology and Tropical Medicine, Schistosomiasis and other Snail-Transmitted Helminthiasis. Watana Panich Press, Bangkok.Google Scholar
  12. Dugernier, T., A. Geubel, G. Bigaignon, J.-Y. Cesbron, and E. Coche. 1986. Human fascioliasis: cure by mebendazole? A case report. Gastroenterol. Clin. Biol. 10:513–516.PubMedGoogle Scholar
  13. Eckert, J., G. Schneiter, and K. Wolff. 1984. FASINEX (Triclabendazole)ein neues fasziolizid. Berliner und Münchner Tierärztliche Wochenschrift 91:349–356.Google Scholar
  14. Gilman, R. H., G. Mondai, M. Maksud, K. Alam, E. Rutherford, J. B. Gilman, and M. U. Khan. 1982. Endemie focus of Fasciolpsis buski infection in Bangladesh. Am. J. Trop. Med. Hyg. 31:796–802.PubMedGoogle Scholar
  15. Hadidjaja, P., H. M. Dahri, R. Roesin, S. S. Margono, J. Djalins, and M. Hanafiah. 1982. First autochtonous case of Fasciolopsis buski infection in Indonesia. Am. J. Trop. Med. Hyg. 31:1065.PubMedGoogle Scholar
  16. Harinasuta, T., D. Bunnag, and P. Radomyos. 1984. Efficacy of praziquantel on fasciolopsiasis. Arzneimittelforsch 34:1214–1215.PubMedGoogle Scholar
  17. Hillyer, G. V. 1975. Use of counterelectrophoresis to detect infections of Fasciola hepatica. J. Parasitol. 61:557–559CrossRefGoogle Scholar
  18. Hillyer, G. V. 1981. Fascioliasis in Puerto Rico a review. Bol. Asoc. Med. P.R. 73:94–101PubMedGoogle Scholar
  19. Hillyer, G. V. 1986. Fascioliasis, paragonimiasis, Clonorchiasis, and opisthorchiasis, p. 39–68. In K. W. Walls and P. M. Schantz (ed.), Immunodiagnosis of parasitic diseases, vol. 1. Academic Press, Inc., New York.Google Scholar
  20. Hillyer, G. V., R. H. Bermudez, and G. Ramírez de Arellano. 1984. Use of immunologic techniques to predict success of therapy in human fascioliasis: a case report. Bol. Asoc. Med. P.R. 76:116–119PubMedGoogle Scholar
  21. Hillyer, G. V., and A. Capron. 1976. Immuodiagnosis of human fascioliasis by counterelectrophoresis. J. Parasitol. 62:1011–1013.PubMedCrossRefGoogle Scholar
  22. Hillyer, G. V., and A. del Llano de Diaz. 1976. Use of immunologic techniques to detect chemotherapeutic success in infection with Fasciola hepatica. I. Rabbit infections. Am. J. Trop. Med. Hyg. 25:307–311PubMedGoogle Scholar
  23. Hillyer, G. V., and L. Sagramoso de Ateca. 1980. Antibody responses in murine schistosomiasis and fascioliasis. Am. J. Trop. Med. Hyg. 29:598–601.PubMedGoogle Scholar
  24. Jones, E. A., J. M. Kay, H. P. Milligan, and D. Owens. 1977. Massive infection with Fasciola hepatica in man. Am. J. Med. 63:836–842.PubMedCrossRefGoogle Scholar
  25. Knobloch, J., A. Delgado, A. Alvarez, U. Reymann, and R. Bialek. 1985. Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel. Trop. Med. Parasit. 36:88–90.Google Scholar
  26. Levine, D. M., G. V. Hillyer, and S. I. Flores. 1980. Comparison of counterelectrophoresis, the enzyme-linked immunosorbent assay, and Kato fecal examination for the diagnossis of fascioliasis in infected mice and rabbits. Am. J. Trop. Med. Hyg. 29:602–608.PubMedGoogle Scholar
  27. Mansour, N. S., F. G. Youssef, E. M. Mikhail, and F. N. Boctor. 1983. Use of partially purified Fasciola gigantica worm antigen in the serological diagnosis of human fascioliasis in Egypt. Am. J. Trop. Med. Hyg. 32:550–554.PubMedGoogle Scholar
  28. Meyers, W. M., and R. C. Neafie. 1976. Fascioliasis (p. 524–527). In C. H. Binford and D. H. Connor (ed.), Pathology of tropical and extraordinary diseases, vol. 2, Armed Forces Institute of Pathology, Washington, D.C.Google Scholar
  29. Naquira-Vildoso, F., and R. Marcial-Rojas. 1971. Fascioliasis, p. 477–489. In R. A. Marcial-Rojas (ed.), Pathology of protozoal and helminthic diseases. The Williams & Wilkins Co., Baltimore.Google Scholar
  30. Noya, M., M. Lema, J. Castillo, L. Rodriguez-Cameselle, and W. M. Ali Al-Shaban. 1982. Parasitaciön por Fasciola hepatica. Claves diagnósticas. Rev. Clin. Esp. 166:177–179.Google Scholar
  31. Pantelouris, E. M. 1965. The common liver fluke. Pergamon Press, Inc., Elmsford, N.Y.Google Scholar
  32. Park, C. I., J. Y. Ro, H. Kim, and Y. Gutierrez. 1984. Human ectopic fascioliasis in the cecum. Am. J. Surg. Pathol. 8:73–77.PubMedCrossRefGoogle Scholar
  33. Pina Arroyo, J., J. García García, J. L. Villar Galan, and A. Gomez Alonso. 1982. Fasciola hepatica en la vía biliar principal. Rev. Esp. Enferm. Apar. Dig. 62:496–501.Google Scholar
  34. Rabbani, G. H., R. H. Gilman, I. Kabir, and G. Mondel. 1985. The treatment of Fasciolopsis buski infection in children: a comparison of thiabendazole, mebendazole, levamisole, pyrantel pamoate, hexylresorcinol and tetrachloroethylene. Trans. R. Soc. Trop. Med. Hyg. 79:513–515.PubMedCrossRefGoogle Scholar
  35. Rim, H.-J. 1982. Fasciolopsiasis, p. 89–97. In J. H. Steele, G.V. Hillyer, and C. E. Hopla (éd.), CRC handbook series in zoonoses. Section C: parasitic zoonoses, vol. III. CRC Press, Inc., Boca Raton, FlaGoogle Scholar
  36. Sadun, E. H., and C. Maiphoom. 1953. Studies on the epidemiology of the human intestinal fluke, Fasciolopsis buski (Lankester) in central Thailand. Am. J. Trop. Med. Hyg. 2:1070–1084.PubMedGoogle Scholar
  37. Santiago, N., and G. V. Hillyer. 1986. Isolation of potential sérodiagnostic Fasciola hepatica antigens by electroelu- tion from polyacrylamide gels. Am. J. Trop. Med. Hyg. 35:1210–1217.PubMedGoogle Scholar
  38. Santiago de Weil, N., G. V. Hillyer, and E. Pacheco. 1984. Isolation of Fasciola hepatica genus-specific antigens. Int. J. Parasitol. 14:197–206.PubMedCrossRefGoogle Scholar
  39. Schacher, J. F., S. Saab, R. Germanos, and N. Boustany. 1969. The aetiology of Halzoun in Lebanon: recovery of Linguatula serrata nymphs from two patients. Trans. R. Soc. Trop. Med. Hyg. 63:854–858.PubMedCrossRefGoogle Scholar
  40. Schiappacasse, R. H., D. Mohammadi, and A. J. Christie. 1985. Successful treatment of severe infection with Fasciola hepatica with praziquantel. J. infect. Dis. 152:1339–1340.PubMedCrossRefGoogle Scholar
  41. Sinclair, K. B. 1967. Pathogenesis of Fasciola and other liver-flukes. Helminthol. Abstr. 36:115–134.Google Scholar
  42. Stoll, N. R., and W. S. Kwei. 1927. Egg-worm correlations in cases of Fasciolopsis buski. J. Parasitol. 13:166–172.CrossRefGoogle Scholar
  43. Uribarrena, R., F. Borda, M. Muñoz, and A. Rivero- Puente. 1985. Laparoscopic findings in eight cases of liver fascioliasis. Endoscopy 17:137–138.PubMedCrossRefGoogle Scholar
  44. Watanabe, S. 1965. A revision of the genus Fasciola in Japan, with particular reference to F. hepatica and F. gigantica. p. 359–381. In K. Morishita, Y. Komiya, and H.Matsubayashi (ed.), Progress of medical parasitology in Japan, vol. II. Meguro Parasitological Museum, TokyoGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1988

Authors and Affiliations

  • George V. Hillyer

There are no affiliations available

Personalised recommendations